YOLFTbeta
00

Wanbangde Pharmaceutical Holding Group Co Ltd

002082 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

9.77CNY-0.35 (-3.46%)

Price History

Full chart

Market Stats

Previous Close10.12
Open10.12
Day Range9.71 – 10.17
52-Week Range8.53 – 36.24
Volume5.35M
Market Cap7.93B
P/E (TTM)0.00
Forward P/E13.44
EPS-0.19
Dividend Yield0.00%
Beta-0.01
50-Day Avg10.02
200-Day Avg16.25

About

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Manufacturing Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells human orthopedic implant devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Shouming Zhao
  • Employees1.35K
  • HeadquartersNo. 28, Baizhang North Road, Taizhou, China, 317500, China
  • Websitehttps://www.wepon.com.cn

Leadership

  • Mr. Shouming ZhaoActing Board Secretary, GM & Chairman of the Board · b. 1964
  • Mr. Zheng JinChief Financial Officer & Accounting Supervisor · b. 1982
  • Mr. Tongke LiuExecutive VP & Director · b. 1965

Financials

Income Statement

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue416.03M535.42M1.17B3.74B4.89B5.84B6.35B8.05B10.87B10.97B11.79B11.45B11.57B9.18B14.64B736.22M16.69B13.70B1.93B1.79B1.54B1.44B1.14B
Growth (%)-+28.70%+119.02%+218.85%+30.83%+19.30%+8.77%+26.88%+35.02%+0.91%+7.41%-2.84%+1.05%-20.64%+59.37%-94.97%+2167.16%-17.91%-85.91%-7.47%-13.69%-6.39%-20.69%
Cost of Revenue369.54M468.69M1.10B3.62B4.74B5.64B6.09B7.74B10.55B10.73B11.51B11.18B11.39B9.01B14.41B160.89M15.27B12.36B999.27M852.57M918.18M847.18M726.95M
Gross Profit46.50M66.72M70.84M122.83M153.87M195.88M262.46M318.19M327.67M240.30M272.78M271.77M181.73M174.83M226.37M575.33M1.43B1.34B931.33M933.85M623.76M596.19M1.14B
Gross Margin11.18%12.46%6.04%3.29%3.15%3.36%4.13%3.95%3.01%2.19%2.31%2.37%1.57%1.90%1.55%78.15%8.54%9.76%48.24%52.27%40.45%41.31%100.00%
Operating Expense15.55M15.54M29.61M65.57M67.28M100.22M110.69M119.61M112.65M111.82M133.72M139.37M100.90M99.62M109.46M386.03M909.07M990.90M556.18M805.19M596.76M536.05M1.32B
Operating Income30.94M51.18M41.23M57.26M86.59M95.66M151.78M198.57M215.02M128.48M139.06M132.40M80.83M75.21M116.91M189.29M516.61M346.60M375.15M128.66M27.00M60.14M-172.32M
Operating Margin7.44%9.56%3.52%1.53%1.77%1.64%2.39%2.47%1.98%1.17%1.18%1.16%0.70%0.82%0.80%25.71%3.10%2.53%19.43%7.20%1.75%4.17%-15.05%
EBITDA46.27M58.56M56.73M106.11M139.32M155.17M207.03M256.36M271.70M194.50M216.34M199.27M144.08M137.54M170.90M251.95M679.93M512.85M492.44M238.79M171.61M194.94M-77.24M
EBITDA Margin11.12%10.94%4.84%2.84%2.85%2.66%3.26%3.18%2.50%1.77%1.84%1.74%1.25%1.50%1.17%34.22%4.07%3.74%25.51%13.37%11.13%13.51%-6.75%
Net Income20.23M25.67M21.38M33.05M63.61M74.05M121.05M151.99M158.64M86.41M111.56M107.53M63.02M69.74M98.21M162.20M294.52M284.94M166.51M93.26M49.21M55.44M-198.78M
Net Income Margin4.86%4.80%1.82%0.88%1.30%1.27%1.91%1.89%1.46%0.79%0.95%0.94%0.54%0.76%0.67%22.03%1.76%2.08%8.62%5.22%3.19%3.84%-17.36%
R&D-----------44.50M49.55M43.36M50.62M46.42M163.37M184.89M76.20M59.10M53.98M59.87M59.16M
R&D as % of Total Revenue-----------0.39%0.43%0.47%0.35%6.31%0.98%1.35%3.95%3.31%3.50%4.15%5.17%
Interest Expense5.20M7.96M13.39M19.29M18.84M20.74M5.60M6.06M16.18M20.00M11.19M2.53M1.07M416.42K865.43K28.86M61.24M57.98M36.87M33.93M47.89M40.34M38.08M
Interest Expense % of Total Revenue1.25%1.49%1.14%0.52%0.39%0.36%0.09%0.08%0.15%0.18%0.09%0.02%0.01%0.00%0.01%3.92%0.37%0.42%1.91%1.90%3.11%2.79%3.33%

Balance Sheet

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets261.57M416.66M661.73M851.57M927.63M1.02B1.12B1.32B1.45B1.57B1.55B1.55B1.62B1.66B2.10B2.85B3.80B5.66B4.37B4.22B4.30B4.33B4.39B
Total Liabilities163.05M280.48M508.84M493.85M512.51M309.46M307.39M380.46M392.22M469.09M361.07M254.69M270.28M261.85M496.58M1.12B1.89B2.80B1.63B1.40B1.54B1.57B1.78B
Total Equity98.53M125.77M143.30M354.02M409.94M705.64M802.89M923.94M1.05B1.09B1.18B1.29B1.34B1.38B1.42B1.49B1.64B2.62B2.60B2.69B2.66B2.67B2.52B
Cash33.26M50.88M145.09M213.62M68.13M181.96M140.79M260.07M153.92M277.62M280.94M260.24M276.14M557.31M280.66M497.34M650.94M574.18M912.02M467.62M226.61M158.73M546.55M
Total Debt112.28M192.28M215.32M272.30M355.90M120.00M86.80M170.00M258.60M285.00M94.00M10.00M5.00M112.10M89.59M532.12M1.36B1.86B840.57M863.01M917.81M969.58M-
Net Debt79.02M141.40M70.23M58.68M287.77M-61.96M-53.99M-90.07M104.68M7.38M-186.94M-250.24M-271.14M-445.21M-191.07M34.78M709.12M1.28B-71.45M395.39M691.20M810.86M255.84M

Cash Flow

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow37.01M32.69M11.23M3.50M12.45M253.06M68.13M162.26M-1.44M202.73M234.35M140.31M16.76M310.71M-17.60M135.40M-248.69M151.01M22.09M-239.65M-72.87M120.22M603.98M
Investing Cash Flow-37.42M-98.23M-95.96M-82.19M-96.40M-143.88M-58.78M-42.67M-132.14M-36.67M-8.37M-78.58M18.53M1.10M-195.80M-426.87M-394.51M-680.64M999.46M-167.42M-156.03M-152.49M-
Financing Cash Flow19.78M81.66M104.33M212.80M-49.01M428.39K-50.34M569.68K30.38M-43.34M-224.77M-87.97M-22.29M-28.81M-59.50M417.80M765.35M439.61M-674.75M-63.07M9.26M-42.33M-
Capital Expenditure37.92M98.30M87.86M93.47M109.68M146.92M60.02M44.02M134.29M40.92M12.45M44.91M30.47M9.03M20.88M199.64M405.98M559.24M277.06M167.23M128.72M88.43M289.65M
Free Cash Flow-907.56K-65.61M-76.63M-89.97M-97.23M106.14M8.12M118.24M-135.73M161.82M221.90M95.40M-13.71M301.68M-38.49M-64.24M-654.67M-408.24M-254.97M-406.88M-201.59M31.79M314.33M
Dividends Paid5.22M8.54M19.51M17.42M26.53M35.51M27.56M35.63M49.40M69.74M29.95M1.97M12.33M23.81M59.50M24.73M50.21M92.73M122.86M43.91M122.03M90.84M47.70M
FCF to OCF-2.45%-200.71%-682.51%-2570.07%-780.73%41.94%11.91%72.87%9446.18%79.82%94.69%67.99%-81.76%97.09%218.62%-47.45%263.24%-270.34%-1154.50%169.78%276.65%26.44%52.04%
Dividend Paid to FCF-575.23%-13.01%-25.46%-19.36%-27.28%33.46%339.47%30.13%-36.40%43.10%13.50%2.07%-89.95%7.89%-154.60%-38.49%-7.67%-22.72%-48.18%-10.79%-60.53%285.74%15.17%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 19, 2014Oct 28, 2014Mar 12, 2015Apr 28, 2015Aug 20, 2015Oct 27, 2015Feb 1, 2016Apr 26, 2016Aug 24, 2016Oct 26, 2016Mar 1, 2017Apr 24, 2017Aug 29, 2017Oct 23, 2017Dec 31, 2017Apr 26, 2018Aug 29, 2018Oct 29, 2018Mar 29, 2019Apr 26, 2019Aug 7, 2019Oct 23, 2019Dec 31, 2019Apr 28, 2020Aug 26, 2020Nov 1, 2020Dec 31, 2020Apr 28, 2021Aug 27, 2021Oct 26, 2021Dec 31, 2021Apr 13, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 25, 2023Aug 28, 2023Oct 26, 2023Dec 31, 2023Apr 25, 2024Aug 28, 2024Sep 30, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual0.040.110.100.060.100.170.180.190.130.240.170.130.070.110.070.110.040.170.090.160.090.140.100.130.040.160.09-0.030.040.120.080.050.030.090.130.160.040.110.070.140.050.180.090.340.080.120.000.270.040.140.070.020.040.050.15-0.090.040.01-0.060.090.050.010.010.020.02-0.00-0.01-0.280.17-0.06
Surprise----------------------------------------------------------------------
Timing---------------------After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hours-After-hours---Pre-marketAfter-hoursPre-market-Pre-marketPre-market--Pre-market-----

Key Statistics & Ratios

Market Cap7.93B
Enterprise Value7.33B
Trailing P/E0.00
Forward P/E13.44
Price / Sales7.04
Price / Book2.70
EPS-0.19
Book Value4.21
Revenue (TTM)1.13B
Gross Profit (TTM)454.37M
EBITDA35.94M
Profit Margin-10.41%
Operating Margin-25.42%
Return on Equity-4.55%
Return on Assets-1.05%
Shares Outstanding611.69M
Shares Float275.24M
Beta-0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.08Jul 11, 2024
20231×
0.12Jun 5, 2023
20211×
0.20May 31, 2021
20201×
0.15Jul 22, 2020
20171×
0.25May 12, 2017
20161×
0.10Apr 15, 2016
20151×
0.05May 19, 2015
20131×
0.08Jun 28, 2013
20121×
0.20Jun 29, 2012
20111×
0.15Jul 5, 2011
20101×
0.13Apr 2, 2010
20091×
0.10May 26, 2009
20081×
0.06Jun 10, 2008
20071×
0.04May 28, 2007

Stock Splits

  • Jun 10, 20081.6:1
  • May 28, 200716:10